Aurinia Pharmaceuticals Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$77,705	$77,114	$73,468	$70,008
Gross Profit	71,200	68,642	64,964	62,893
EBITDA	49,753	47,068	36,827	28,137
EBIT	44,937	42,204	31,962	23,273
Net Income	34,355	210,794	31,551	21,513
Net Change In Cash	77,705	77,114	73,468	70,008
Free Cash Flow	32,521	44,501	44,384	44,143
Cash	41,008	80,213	73,189	53,002
Basic Shares	137,639	138,700	136,008	143,199

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$283,055	$235,133	$175,513	$134,030
Gross Profit	250,390	206,885	161,365	128,366
EBITDA	127,757	31,728	-63,047	-108,764
EBIT	118,487	12,283	-74,694	-111,470
Net Income	287,202	5,752	-78,020	-108,180
Net Change In Cash	283,055	235,133	175,513	134,030
Free Cash Flow	135,406	44,107	-34,179	-79,821
Cash	80,213	83,433	48,875	94,172
Basic Shares	138,700	146,194	143,236	141,915